Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 13, 2018 - The FDA approved an update to the Warnings and Precautions section of the Viberzi (eluxadoline) drug label regarding constipation.
Download PDF
Return to publications
